Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back

Enrique Soriano, MD, MSc

Hospital Italiano de Buenos Aires
Buenos Aires, Argentina

Dr Enrique Soriano is Medical specialist in Internal Medicine and Rheumatology.
Master’s in clinical Effectiveness from the University of Buenos Aires.
Associate Professor at the University Institute Hospital Italiano de Buenos Aires
Head of the Rheumatology Section of the Hospital Italiano de Buenos Aires between 2010 and 2020.
President of PANLAR (Pan American League of Associations for Rheumatology) between 2018 and 2020
President of the Argentine Society of Rheumatology between 2016 and 2018.
PANLAR Master in 2023
His research interest in Rheumatology focuses on psoriatic arthritis, spondyloarthritis, rheumatoid arthritis and autoimmune diseases, with more than 180 papers published in pubMed-indexed journals.

Presentation(s):

  • 12S149: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Treatment I: PsA (0775–0780)

    Sunday, November 12, 2023
    2:00 PM – 3:30 PM PT

    Disclosure(s): Abbvie: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Grant/Research Support (Terminated, May 18, 2023), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, May 18, 2023); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • 1438: Efficacy of Guselkumab in Early-Onset and Late-Onset Psoriatic Arthritis: Post Hoc Pooled Analyses of Two Phase 3 Randomized Controlled Trials in Patients with Active PsA

    Monday, November 13, 2023
    9:00 AM – 11:00 AM PT

    Disclosure(s): Abbvie: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Grant/Research Support (Terminated, May 18, 2023), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, May 18, 2023); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • 334: Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster Tour

    Tuesday, November 14, 2023
    10:15 AM – 11:00 AM PT

    Disclosure information not submitted.